RECOMBINANT ERYTHROPOIETIN AS TREATMENT FOR THE LATE HYPOREGENERATIVE ANEMIA OF RH HEMOLYTIC-DISEASE

被引：0
|
作者：
OHLS, RK [1 ]
WIRKUS, PE [1 ]
CHRISTENSEN, RD [1 ]
机构：
[1] UNIV UTAH,SCH MED,DIV NEONATOL,SALT LAKE CITY,UT 84132
来源：
PEDIATRICS | 1992年 / 90卷 / 05期
关键词：
ERYTHROPOIETIN; RH HEMOLYTIC DISEASE; ANEMIA; NEONATES;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Infants with Rh hemolytic disease can develop a ''late'' anemia characterized by low serum concentrations of erythropoietin but erythroid progenitors that remain highly erythropoietin-responsive. Erythropoietin administration was evaluated in two patients as an alternative to transfusion. Reticulocyte counts increased after 5 days of treatment, and hematocrits increased after 10 days. Neither patient received erythrocyte transfusions following erythropoietin therapy.
引用
收藏
页码：678 / 680
页数：3
相关论文
共 50 条
  • [41] INTRAVENOUSLY ADMINISTERED IMMUNE GLOBULIN FOR RH HEMOLYTIC-DISEASE
    RAO, R
    SARKAR, S
    NARANG, A
    JOURNAL OF PEDIATRICS, 1993, 122 (05): : 833 - 833
  • [42] FETAL BLOOD-SAMPLING IN RH HEMOLYTIC-DISEASE
    POLLOCK, JM
    BOWMAN, JM
    MANNING, FA
    HARMAN, CR
    VOX SANGUINIS, 1987, 53 (03) : 139 - 142
  • [43] ERYTHROPOIETIN IN RHESUS HEMOLYTIC-DISEASE DURING PREGNANCY AND IN THE FIRST TRIMENON
    DAME, C
    SCHLEBUSCH, H
    BALD, R
    HANSMANN, M
    FAHNENSTICH, H
    PEDIATRIC RESEARCH, 1995, 38 (03) : 430 - 430
  • [44] Recombinant Human Erythropoietin in the Prevention of Late Anemia in Intrauterine Transfused Neonates With Rh-isoimmunization
    Zuppa, Antonio Alberto
    Alighieri, Giovanni
    Calabrese, Valentina
    Visintini, Federica
    Cota, Francesco
    Carducci, Chiara
    Antichi, Eleonora
    Noia, Giuseppe Antonio
    Fortunato, Giuseppe
    Romagnoli, Costantino
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (03) : E95 - E101
  • [45] Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin
    Wacker, P
    Ozsahin, H
    Stelling, MJ
    Humbert, J
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2001, 18 (04) : 279 - 282
  • [46] THE RH ANTIGEN TAR (RH40) CAUSING HEMOLYTIC-DISEASE OF THE NEWBORN
    LEVENE, C
    SELA, R
    GRUNBERG, L
    GALE, R
    LOMAS, C
    TIPPETT, P
    CLINICAL AND LABORATORY HAEMATOLOGY, 1983, 5 (03): : 303 - 305
  • [47] RECOMBINANT-HUMAN-ERYTHROPOIETIN MAY CORRECT ERYTHROPOIETIN-DEFICIENT HYPOREGENERATIVE ANEMIA IN CHILDREN GIVEN CARDIAC TRANSPLANTATION
    LOCATELLI, F
    ZECCA, M
    MAMPRIN, F
    GAMBA, A
    GIORGIANI, G
    DESTEFANO, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (03) : 623 - 625
  • [48] CLINICAL CHARACTERISTICS OF RH-E HEMOLYTIC-DISEASE OF THE NEWBORN
    JIN, HZ
    ZHENG, Y
    CHINESE MEDICAL JOURNAL, 1987, 100 (05) : 393 - 401
  • [49] SEVERE HEMOLYTIC-DISEASE IN AN INFANT BORN TO AN RH(NULL) PROPOSITA
    LUBENKO, A
    CONTRERAS, M
    PORTUGAL, CL
    CERVI, P
    FORSI, L
    GARNER, SF
    PINHO, MO
    BARBOSA, M
    METTRAU, EC
    DEAZEVEDO, JG
    VOX SANGUINIS, 1992, 63 (01) : 43 - 47
  • [50] Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question
    Alaqeel, Aqeel Abdullah
    PAN AFRICAN MEDICAL JOURNAL, 2019, 32
12345